The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been down 0.4% at 8,261 points.

Investors reacted with disappointment to the latest Chinese stimulus measures released on the weekend. Declining iron ore and oil prices has adversely affected commodity stocks, as hopes of a strong uptick in Chinese driven demand were dashed.

IT and Real Estate have been the best performing sectors, both up 1%, followed by Health Care and Discretionary, both up around a third of a percent.

Materials has been the worst performer, down 2.4%, followed by Staples, down 1.7% and Energy, down 0.8%.

Company News

Resoulute Mining (ASX:RSG) has been down 30% on news its CEO Terry Holohan and other company executives have been detained by the military controlled government of Mali in West Africa.

Resolute Mining has been 47 cents.

Imugene (ASX:IMU) has been up 4.4% on news its kicked off the injection phase of a trial of its innovative onCARlytics (CF33-CD19) candidate. This pivotal development marks the dosing of the first patient grappling with advanced solid tumours.

Imugene has been 4.8 cents.

Li-S Energy (ASX:LIS) has been up 5.7% on reports it used a twelve-cell lithium sulfur battery pack to power a small UAV for 30 minutes. The fixed wing asset, which doesn’t use quadcopter style propellors and instead was hand launched, stayed airborne for half an hour – and didn’t even use up all the battery’s life.

Li-S Energy has been 23.3 cents.

More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…